Understanding the mechanism of the water drinking test: The role of fluid challenge volume in patients with medically controlled primary open angle glaucoma

Clinical and Experimental Ophthalmology

Volumn 38, Issue 1, 2010, Pages 4-9

  Kerr, Nathan M ^a   Danesh Meyer, Helen V ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Glaucoma; Intraocular pressure; Water drinking

Indexed keywords

DRINKING WATER;

AGE; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FLUID INTAKE; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; RANDOMIZED CONTROLLED TRIAL; TONOMETER; WATER LOADING;

AGED; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DRINKING; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; PERIMETRY; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; VISUAL ACUITY; WATER;

EID: 77950937108     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2009.02183.x     Document Type: Article

References (41)

1. Kass MA, Heuer DK, Higginbotham EJ. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002, 120:701-13. for the Ocular Hypertension Treatment Study G
2. O'Brien C, Schwartz B, Takamoto T, Wu DC. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol 1991, 111:491-500.
3. Schulzer M, Mikelberg FS, Drance SM. Some observations on the relation between intraocular pressure reduction and the progression of glaucomatous visual loss. Br J Ophthalmol 1987, 71:486-8.
4. David R, Zangwill L, Briscoe D, Dagan M, Yagev R, Yassur Y. Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. Br J Ophthalmol 1992, 76:280-3.
5. Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open angle glaucoma or ocular hypertension. J Glaucoma 2001, 10:414-22.
6. Susanna R, Hatanaka M, Vessani RM, Pinheiro A, Morita C. Correlation of asymmetric glaucomatous visual field damage and water-drinking test response. Invest Ophthalmol Vis Sci 2006, 47:641-4.
7. Susanna R, Vessani RM, Sakata L, Zacarias LC, Hatanaka M. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol 2005, 89:1298-301.
8. Danesh-Meyer HV. The water-drinking test: the elegance of simplicity. Clin Experiment Ophthalmol 2008, 36:301-3.
9. Danesh-Meyer HV, Papchenko T, Tan Y-W, Gamble GD. Medically controlled glaucoma patients show greater increase in intraocular pressure than surgically controlled patients with the water drinking test. Ophthalmology 2008, 115:1566-70.
10. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 2002, 120:1268-79. for the Early Manifest Glaucoma Trial G
11. Anderson D. Automated Static Perimetry 1999, 2nd, edn., St. Louis, Mosby
12. Gordon MO, Beiser JA, Brandt JD. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002, 120:714-20. for the Ocular Hypertension Treatment Study G
13. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003, 121:48-56. for the Early Manifest Glaucoma Trial G
14. Bergea B, Bodin L, Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology 1999, 106:997-1004.
15. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991, 111:51-5.
16. Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 1993, 116:176-81.
17. Stewart WC, Sine CS, LoPresto C. Surgical vs medical management of chronic open-angle glaucoma. Am J Ophthalmol 1996, 122:767-74.
18. Vogel R, Crick RP, Newson RB, Shipley M, Blackmore H, Bulpitt CJ. Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol 1990, 74:3-6.
19. Wilensky JT. Diurnal variations in intraocular pressure. Trans Am Ophthalmol Soc 1991, 89:757-90.
20. Zeimer RC, Wilensky JT, Gieser DK, Viana MAG. Association between intraocular-pressure peaks and progression of visual-field loss. Ophthalmology 1991, 98:64-9.
21. Drance S. Diurnal variation of intraocular pressure in treated glaucoma: significance in patients with chronic simple glaucoma. Arch Ophthalmol 1963, 70:302-11.
22. Frankelson EN. The role of the water test in evaluation of glaucoma control. Can J Ophthalmol 1974, 9:408-10.
23. Vasconcelos-Moraes CG, Susanna R. Correlation between the water drinking test and modified diurnal tension curve in untreated glaucomatous eyes. Clinics 2008, 63:433-6.
24. Miller D. The Relationship between diurnal tension variation and the water-drinking test. Am J Ophthalmol 1964, 58:243-6.
25. Schmidt K. Untersuchungen uber Kapillarendothelstorungen bei Glaukoma simplex. Arch Augenheilkd 1928, 98:569-81.
26. Rasmussen KE, Jorgensen HA. Diagnostic value of the water-drinking test in early detection of simple glaucoma. Acta Ophthalmol 1976, 54:160.
27. Roth JA. Inadequate diagnostic value of the waterdrinking test. Br J Ophthalmol 1974, 58:55.
28. Armaly MF. Lessons to be learned from the Collaborative Glaucoma Study. Surv Ophthalmol 1980, 25:139.
29. Yoshikawa K, Inohue T, Inohue Y. Normal tension glaucoma: the value of predictive tests. Acta Ophthalmol 1993, 71:463-70.
30. Christiansen GA, Nau CB, McLaren JW, Johnson DH. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology 2004, 111:1658-62.
31. Sussana R, Sheu W-P, Society LAG. Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: An eight-week, randomized, open-label, parallel-group, multicenter study in Latin America. Clin Ther 2004, 26:755-68.
32. Vetrugno M, Sisto D, Trabucco T, Balducci F, Noci ND, Sborgia C. Water-drinking test in patients with primary open-angle glaucoma while treated with different topical medications. J Ocul Pharmacol Ther 2005, 21:250-7.
33. Chen C-H, Lu D-W, Chang C-J, Chiang C-H, Chou P-I. The application of water drinking test on the evaluation of trabeculectomy patency. J Ocul Pharmacol Ther 2000, 16:37-42.
34. Medeiros FA, Pinheiro A, Moura FC, Lea BC, Susanna RI. Intraocular pressure fluctuations in medically versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 2002, 18:489-98.
35. Spaeth GL, Vacharat N. Provocative tests and chronic simple glaucoma. I. Effect of atropine on the water-drinking test: intimations of central regulatory control. II. Fluorescein angiography provocative test: a new approach to separation of the normal from the pathological. Br J Ophthalmol 1972, 56:205-16.
36. Brubaker RF. Importance of outflow facility. Int Glaucoma Rev 2001, 3:5.
37. Friberg TR, Sanborn G, Weinreb RN. Intraocular and episcleral venous pressure increase during inverted posture. Am J Ophthalmol 1987, 103:523-6.
38. Friberg TR, Weinreb RN. Ocular manifestations of gravity inversion. J Am Med Assoc 1985, 253:1755-7.
39. Hayreh SS. Acute occlusive disorders of the choroidal vasculature. Int Ophthalmol 1983, 6:139-48.
40. Leydhecker W. The water-drinking test. Br J Ophthalmol 1950, 34:457-79.
41. Konstas AG, Maltezos AC, Gandi S, Hudgins AC, Stewart WC. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma. Am J Ophthalmol 1999, 128:15.